Target intelligence / Profile preview

Host translation initiation factors interacting with poliovirus IRES domain V (eIF4G-IRES Domain V complex)

Target
eIF4G-IRES Domain V complex
Molecular classification
Translation initiation factor, RNA-binding protein, Enzyme, Ribonucleoprotein complex
01

Overview

Domain V of the poliovirus internal ribosome entry site (IRES) is a critical RNA structure that recruits host translation initiation factors to facilitate cap-independent viral protein synthesis. The primary host factors involved are the eIF4G/eIF4A complex, which binds to the lower part of Domain V, and eIF4B, which binds to the upper part. Additionally, glycyl-tRNA synthetase (GARS) and the cold shock domain-containing protein E1 (UNR/CSDE1) interact with the apical region of Domain V to stabilize the initiation complex and promote 40S ribosomal subunit recruitment. Mutations in Domain V, such as those found in the Sabin vaccine strains, impair these interactions and are major determinants of viral attenuation and neurovirulence. Targeting this interaction with small molecules or nucleic acid-based therapies represents a strategy for developing antivirals against poliovirus and related enteroviruses. Experimental inhibitors include eIF4A inhibitors like silvestrol and hippuristanol, which prevent the necessary RNA unwinding for ribosome entry, as well as antisense oligonucleotides that sterically block host factor binding sites. While effective in suppressing viral replication, therapeutic challenges include the potential for off-target effects on cellular mRNAs that utilize IRES-mediated translation and the high mutation rate of the viral genome.

Other names
Poliovirus IRES Domain V binding proteinsIRES trans-acting factors (ITAFs) for PolioviruseIF4G/eIF4A/eIF4B/GARS/UNR complexPoliovirus IRES-host factor interaction
02

Mechanism of action

Inhibition of viral translation by blocking the recruitment of the 40S ribosomal subunit or disrupting the interaction between host factors and the IRES Domain V.

03

Biological functions

Translation initiationViral replicationCap-independent translationRibosome recruitment
04

Disease associations

InfectionPoliomyelitis
05

Safety considerations

Off-target inhibition of cellular IRES-mediated translationToxicity associated with systemic eIF4A inhibitionPotential for viral resistance mutations in the IRES sequence
06

Interacting drugs

Silvestrol

4 more in the full profile.

07

Biomarkers

Poliovirus RNA levelsViral protein VP1 expressionViral titer (plaque assay)

Beyond the preview

Go deeper on Host translation initiation factors interacting with poliovirus IRES domain V (eIF4G-IRES Domain V complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host translation initiation factors interacting with poliovirus IRES domain V (eIF4G-IRES Domain V complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call